NYSE:AFL
AFLAC INC
A dominant player in supplemental health insurance offering affordable accident and long-term care protection to millions of American consumers.
Key Metrics
Investment Thesis
Bull Case
AFLAC offers an attractive dividend yield backed by a fortress balance sheet with over $6B in cash, making it a resilient income play for value investors seeking exposure to the growing demand for supplemental health coverage as Medicare gaps widen.
Bear Case
The sharp contraction in net income from 2024 to 2025 raises concerns about margin pressure or claims volatility that may persist, while the massive treasury stock and negative non-controlling interests suggest complex capital structure dynamics that warrant caution.
About AFLAC INC
AFLAC Inc. is a leading provider of supplemental health insurance products, including accident and long-term care coverage, primarily serving the US market through direct-to-consumer channels and partnerships with employers and healthcare providers.
Analysis
Management Discussion
Despite a slight revenue decline to $17.16B in the latest year compared to the 2024 figure, the company reported a net profit of $3.65B, though this represents a notable drop from the previous years' highs above $5B. The significant cash flow from operations of $2.56B and substantial share repurchases of $3.53B indicate a strong balance sheet focused on returning capital to shareholders despite recent earnings compression.
Industry Overview
The US supplemental health insurance industry is characterized by high customer loyalty once policies are purchased but faces constant pressure from rising medical inflation and increasing regulatory scrutiny regarding underwriting practices and benefit design.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $19.50B | $18.70B | $18.93B | $17.16B |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $19.50B | $18.70B | $18.93B | $17.16B |
| Operating Expenses | $15.35B | $13.44B | $12.51B | $12.63B |
| Operating Income | $4.16B | $5.26B | $6.42B | $4.53B |
| G&A | $3.25B | $3.17B | $3.01B | $3.25B |
| D&A | $45.0M | $39.0M | $40.0M | $36.0M |
| Other OpEx | $12.10B | $10.27B | $9.50B | $9.38B |
| Non-Operating Income | $447.0M | $0 | $0 | $0 |
| Interest Expense | $226.0M | $195.0M | — | — |
| Pre-Tax Income | $4.60B | $5.26B | $6.42B | $4.53B |
| Income Tax | $403.0M | $603.0M | $974.0M | $887.0M |
| Continuing Ops | $4.20B | $4.66B | $5.44B | $3.65B |
| Discontinued Ops | $0 | $0 | $0 | $0 |
| Net Income | $4.20B | $4.66B | $5.44B | $3.65B |
| Minority Interest | $0 | $0 | $0 | $0 |
| Net to Common | $4.20B | $4.66B | $5.44B | $3.65B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $3.94B | $4.31B | $6.23B | $6.25B |
| PP&E (Net) | $530.0M | $445.0M | $387.0M | $351.0M |
| Goodwill | $265.0M | $265.0M | $263.0M | $260.0M |
| Total Assets | $131.02B | $126.72B | $117.57B | $116.47B |
| Total Liabilities | $108.65B | $104.74B | $91.47B | $86.98B |
| Shareholders' Equity | $22.36B | $21.98B | $26.10B | $29.49B |
| Retained Earnings | $44.57B | $47.99B | $52.28B | $54.68B |
| AOCI | $-4.41B | $-5.52B | — | — |
| Treasury Stock | $20.57B | $23.39B | $26.23B | $29.80B |
| Total L&E | $131.02B | $126.72B | $117.57B | $116.47B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $4.20B | $4.66B | $5.44B | $3.65B |
| Non-Cash Adjustments | $-423.0M | $-83.0M | $-1.99B | $-64.0M |
| Working Capital Changes | $101.0M | $-1.39B | $-746.0M | $-1.03B |
| Cash from Operations | $3.88B | $3.19B | $2.71B | $2.56B |
| Cash from Investing | $-1.54B | $817.0M | $2.78B | $1.56B |
| Share Buybacks | $2.40B | $2.80B | $2.80B | $3.53B |
| Dividends Paid | $979.0M | $966.0M | $1.09B | $1.20B |
| Cash from Financing | $-3.55B | $-3.72B | $-3.49B | $-4.07B |
| FX Effect | $104.0M | $79.0M | $-79.0M | $-31.0M |
| Net Change in Cash | $-1.11B | $363.0M | $1.92B | $16.0M |
| Beginning Cash | $5.05B | $3.94B | $4.31B | $6.23B |
| Ending Cash | $3.94B | $4.31B | $6.23B | $6.25B |
Frequently Asked Questions
How does AFLAC INC make money?
The company generates revenue primarily from premiums for accident health insurance, long-term care insurance, and disability income products sold directly to individuals and through third-party distribution channels such as hospitals, doctors, and employers.
What are the main risks for AFL?
Investors should consider risks related to rising healthcare costs and claims inflation, potential regulatory changes affecting insurance operations, interest rate sensitivity impacting investment portfolio returns, and competition from larger carriers like MetLife or UnitedHealth Group.
What is AFL's competitive advantage?
AFLAC benefits from a massive installed base of policyholders, low-cost digital underwriting processes, and strong brand recognition in the supplemental insurance space that allows for efficient customer acquisition and retention.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.